| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 06/20/2007 | EP1012329B1 Diagnosis and treatment of myocardial failure |
| 06/20/2007 | CN1984906A Condensed benzamide compounds and inhibitors of vanilloid receptor subtype 1 (VR1) activity |
| 06/20/2007 | CN1984682A Solid medicinal preparation |
| 06/20/2007 | CN1984681A Agent for promoting the recovery from dysfunction after the onset of central neurological disease |
| 06/20/2007 | CN1984664A Methods for treating bleeding disorders using sulfated polysaccharides |
| 06/20/2007 | CN1984652A Using methods and compositions comprising selective cytokine inhibitory drugs for treatment and management of myeloproliferative diseases |
| 06/20/2007 | CN1984651A Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases |
| 06/20/2007 | CN1984648A Botanical extract compositions and methods of use |
| 06/20/2007 | CN1981872A Use of PUMA in tumor chemoradiotherapy sensibilization |
| 06/20/2007 | CN1981869A Compound non-carrier antibacterial eye drops containing practofren and its production |
| 06/20/2007 | CN1981868A Combined use of anti-cytokine antibodies or antagonists and anti-CD20 for treatment of B cell lymphoma |
| 06/20/2007 | CN1981780A Strontium compound for treatment of sub-dermal soft tissue pain |
| 06/20/2007 | CN1981761A Methods and compositions using immune regulative compound for treatment and management of cancers and other diseases |
| 06/20/2007 | CN1981741A Method of improving biological utilization degree of precursor medicament using self-emulsification delivering system |
| 06/20/2007 | CN1981738A Stomach resorting agent of cephalosporin and preparation method thereof |
| 06/20/2007 | CN1322114C Anti-tumor and antiviral medicine and production method thereof |
| 06/20/2007 | CN1321688C Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation |
| 06/20/2007 | CN1321683C Use of neurotoxin therapy for treatment of urologic and related disorders |
| 06/20/2007 | CN1321682C New dipeptidyl peptidase iv inhibitors and their uses as anti-cancer agents |
| 06/20/2007 | CN1321635C Binding partners for 5-HT5 receptors for treatment of migraine |
| 06/19/2007 | US7232906 Kinase inhibitors; antiinflammatory agents; respiratory system disorders; cardiovascular disorders; antidiabetic agents |
| 06/19/2007 | US7232819 Dihydroxypyrimidine carboxamide inhibitors of HIV integrase |
| 06/19/2007 | US7232804 Use of KPV tripeptide for dermatological disorders |
| 06/19/2007 | US7232803 Molecule comprising backbone of 2-35 non-hydrogen atoms in length, having covalently attached bulky lipoophilic groups and having more cationic than anionic moiety in manufacturing medicament for destabilising microbial cell membranes |
| 06/19/2007 | US7232801 Administering a peptide whose sequence coincide with regions of the IL-16 receptor (CD4) to interfere with or prevent binding to an IL-16 receptor; treating asthma, arthritis, IBD, Systemic Lupus, multiple sclerosis, Graves opthalmopathy, atopic rhinitis, atopic dermatitis and bullous pemphigoid |
| 06/19/2007 | US7232796 Polypeptide for use as a medicament for treating bone defects, bone diseases and for improving bone regeneration |
| 06/19/2007 | US7232575 Nutrient supplements and methods for treating autism and for preventing the onset of autism |
| 06/19/2007 | CA2437468C Sensitization of chemotherapeutic agent resistant neoplastic cells with reovirus |
| 06/19/2007 | CA2352515C Methods for identifying combinations of entities as therapeutics |
| 06/19/2007 | CA2276429C Compositions for the treatment of ards or irds containing 3-(cyclopropylmethoxy)-n-(3,5-dichloro-4-pyridinyl)-4-(difluoromethoxy)benzamide and lung surfactant |
| 06/19/2007 | CA2238621C Novel drug for relieving pain and promoting the removal of calculi in urolithiasis |
| 06/19/2007 | CA2166179C Use of a tnf-alpha antagonist in a cosmetic, pharmaceutical or skincare composition and composition thus obtained |
| 06/19/2007 | CA2066738C Prevention, treatment and amelioration of a pathology characterized by brain inflammation |
| 06/14/2007 | WO2007068007A1 Use of a disinfectant for treating respiratory tract infections |
| 06/14/2007 | WO2007066889A1 Compositions for external application, containing adenosyl cobalamin for improvement of skin diseases |
| 06/14/2007 | WO2007065314A1 Compound preparation for treating virus hepatopathy |
| 06/14/2007 | WO2007034188A3 Chemo-immunotherapy method |
| 06/14/2007 | WO2007010014A3 Compositions for treatment of systemic mastocytosis |
| 06/14/2007 | WO2007004685A3 Compositions for ameliorating a reduced higher brain function resulting from organic brain lesions |
| 06/14/2007 | WO2006100213A8 Composition comprising a combined thromboxane receptor antagonist and thromboxane synthase inhibitor and a cox-2 inhibitor |
| 06/14/2007 | WO2006040755A3 Novel methods for the in-vitro identification, isolation and differentiation of vasculogenic progenitor cells |
| 06/14/2007 | WO2005051308A3 Methods of treating diseases and disorders by targeting multiple kinases |
| 06/14/2007 | WO2004049904A3 Bioactive, resorbable scaffolds for tissue engineering |
| 06/14/2007 | WO2004043335A3 Methods of treating infection by drug resistant bacteria |
| 06/14/2007 | US20070136829 Novel type-1 cytokine receptor glm-r |
| 06/14/2007 | US20070136828 Methods of using molecules related to organic cation transporter 3 (oct3) for treating depression, anxiety neuroses, drug dependencies, and other similar mental disorders |
| 06/14/2007 | US20070135929 Biocompatibility; biopolymers such as poly-4-hydroxybutyrate, poly-4-hydroxybutyrate-co-3-hydroxybutyrate, poly-4-hydroxybutyrate-co-2-hydroxybutyrate, and copolymers and blends; controlled degradation rate; grafting |
| 06/14/2007 | US20070135514 Methods for the identification of agents for the treatment of seizures, neurological diseases, endocrinopathies and hormonal diseases |
| 06/14/2007 | US20070135505 Aralkyl ester soft drugs |
| 06/14/2007 | US20070135462 AZD2171 or salts except the maleate salt with a taxane; AZD2171 is 4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-6-methoxy-7-(3-(pyrrolidin-1-yl)propoxy)quinazoline, aka cediranib |
| 06/14/2007 | US20070135444 Treatment of neuroblastoma |
| 06/14/2007 | US20070135404 e.g. N-[1-(2-aminoethyl)-4-piperidinyl]-7-methyl-3-(8-quinolinylmethyl)-3H-imidazo[4,5-b]pyridin-2-amine tetrahydrochloride trihydrate; immunostimulant; lower respiratory tract illness during infancy and childhood, asthma, pneumonia |
| 06/14/2007 | US20070135381 Derivatives of branch-chain lipophilic molecular and uses thereof |
| 06/14/2007 | US20070135371 Antisense IAP nucleobase oligomers and uses thereof |
| 06/14/2007 | US20070135366 evaluating the amount of cancer cells existing in pancreatic cells or tissues, by measuring the methylation frequency of Fibrillin2 gene or an index value having the correlation therewith, and comparing with a control; medical diagnosis |
| 06/14/2007 | US20070135361 Method of diagnosing alzheimer's disease by detection of chlamydia pneumoniae |
| 06/14/2007 | US20070135360 Determining whether cerebralspinal fluid sample contains Chlamydia pneumoniae |
| 06/14/2007 | US20070135354 Hematopoietic stimulation |
| 06/14/2007 | US20070134758 Methods of inhibiting hiv-1 vpr activity and hiv-1 infectivity using atr or rad17 inhibitors |
| 06/14/2007 | US20070134744 Epothilone resistant cell lines |
| 06/14/2007 | US20070134735 Transcriptional regulation of the human beta3-adrenergic receptor gene |
| 06/14/2007 | US20070134719 Method of controlling pharmacokinetics of immunomodulatory compounds |
| 06/14/2007 | US20070134693 Method for modulating the binding activity of a novel ICAM-3 binding receptor on sinusoidal endothelial cells in liver and lymph nodes |
| 06/14/2007 | US20070134308 Non-steroidal anti-inflammatory drug formulations for topical applications to the skin |
| 06/14/2007 | US20070134273 Composition and method for the treatment of carcinoma |
| 06/14/2007 | US20070134262 Polypeptide encoded by an alternative reading frame of a pathogenic virus or a fragment comprising more than 7 amino acids; Hepatitis A virus, Hepatitis B virus, Hepatitis C virus, Hepatitis D virus, Hepatitis E virus, Hepatitis F virus Hepatitis G virus, Human Immunodeficiency virus, Influenza virus |
| 06/14/2007 | US20070134250 Composition Comprising and Method of Using Angiopoietin-Like Protein 3 ANGPTL3 |
| 06/14/2007 | US20070134242 Mesothelioma therapeutic agent |
| 06/14/2007 | US20070134198 Composition and use of RAR antagonists for promoting chondrogenesis |
| 06/14/2007 | US20070134183 Aminosulfonic acid compounds for promoting desquamation of the skin |
| 06/14/2007 | DE102005058345A1 Verwendung eines oral einzunehmenden Antibiotikums Use of orally administered antibiotic |
| 06/14/2007 | DE10103565B4 Zusammensetzungen, enthaltend einen Ruthenium(III)-komplex und einen Heterocyclus Compositions comprising a ruthenium (III) complex and a heterocycle |
| 06/14/2007 | CA2632754A1 Methods for identifying and targeting tumor stem cells based on nuclear morphology |
| 06/14/2007 | CA2632544A1 Use of myostatin antagonist for treating the effects of hypogonadism |
| 06/14/2007 | CA2630624A1 Compositions and methods for increasing insulin sensitivity |
| 06/13/2007 | EP1795598A1 Novel peptides |
| 06/13/2007 | EP1795531A1 A thiazolidinedione derivative and its use as antidiabetic |
| 06/13/2007 | EP1795207A1 Solid pharmaceutical preparation |
| 06/13/2007 | EP1795206A1 Drug for treating or preventing hcv infection |
| 06/13/2007 | EP1795196A2 Method of treating lower urinary tract disorders |
| 06/13/2007 | EP1795194A2 Use of an antagonist of CB1 receivers associated with a beta3-agonist for preparing medication to be used for treating appetence |
| 06/13/2007 | EP1793818A2 Pindolol for treating premenstrual syndrome and premenstrual dysphoric disorder |
| 06/13/2007 | EP1793814A2 Thyroid hormone analogs for promoting angiogenesis |
| 06/13/2007 | EP1793678A1 Dendritic cell tumor injection (dcti) therapy |
| 06/13/2007 | EP1408988B1 Compositions of orally administered nutritional supplements to repair articular cartilage |
| 06/13/2007 | EP1387844B1 Retinol derivatives potentiation of active substances by micellar preparation |
| 06/13/2007 | EP1357944B1 Perylenequinones for use with immunotherapy agents |
| 06/13/2007 | EP1353726B1 Rehydration composition |
| 06/13/2007 | EP1326611B1 Aza- and polyaza-naphthalenyl-carboxamides useful as hiv integrase inhibitors |
| 06/13/2007 | EP1302542B1 Novel physiologically active peptide and use thereof |
| 06/13/2007 | EP1299358B1 Pyridoxine and pyridoxal analogues as cardiovascular therapeutics |
| 06/13/2007 | EP1276474B1 Formulations for use in inhaler devices |
| 06/13/2007 | EP1276469B1 Taste masking coating composition |
| 06/13/2007 | EP1267925B1 Treatment of fungal infection with polyene or beta glucan synthase inhibitor antifungals combined with anti hsp90 antibodies |
| 06/13/2007 | EP1230349B1 Nucleic acids encoding endotheliases, endotheliases and uses thereof |
| 06/13/2007 | EP1173548B1 Materials and methods for the production of dopaminergic neurons |
| 06/13/2007 | EP1171104B1 Transdermal therapeutic system with neutralized acrylic adhesive patch |
| 06/13/2007 | EP1140969B1 Connective tissue growth factor fragments and methods and uses thereof |
| 06/13/2007 | EP1100895B1 Abc1 polypeptide and methods and reagents for modulating cholesterol levels |
| 06/13/2007 | EP1027429B1 Jnk3 modulators and methods of use |